EC
GMDA

EcoR1 Capital’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

EcoR1 Capital’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-52,120
Closed -$265K – 46
2019
Q2 		$265K Buy
+52,120
New +$409K 0.03% 38

Other funds holding GMDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NC
Noked Capital Tel Aviv, Israel $946M AUM 17.1% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $970M AUM 74.09% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

EcoR1 Capital's GMDA Position: Q3 2019 in Review

EcoR1 Capital sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q3 2019, closing a stake of 52,120 shares — an estimated $265K sold.

EcoR1 Capital first reported a position in GMDA in Q2 2019 and held it in 1 quarter. The position peaked at $265K in Q2 2019. 13 funds tracked by Wall St. Rank hold GMDA as of Q3 2019.

  • EcoR1 Capital reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • EcoR1 Capital sold 52,120 Gamida Cell Ltd. Ordinary Shares shares in Q3 2019, an estimated $265K.
  • EcoR1 Capital first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2019 and held it in 1 quarter.
  • EcoR1 Capital's Gamida Cell Ltd. Ordinary Shares position peaked at $265K in Q2 2019.
  • 13 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q3 2019.

Based on EcoR1 Capital's 13F filing for Q3 2019, filed 14 Nov 2019.